Results 71 to 80 of about 5,707 (185)
Plasma Leptin Levels Before and After Bromocriptine Treatment in Female Patients with Prolactinoma
Both It is known that increased body weight is associated with prolactinomas. However, effects of bromocriptine treatment on plasma leptin levels is not clear yet.
Metin Özata +2 more
doaj
Transcriptomic analysis of the anti-tumor effects of leflunomide in prolactinoma
Leflunomide’s anti-tumor effects have been investigated in various types of tumors; however, its impact on pituitary adenoma, particularly prolactinoma, is unclear.
Xiangdong Pei +6 more
doaj +1 more source
Objective: There may be an association between hyperprolactinemia and autoimmune diseases, possibly because of the immunostimulatory effect of prolactin.
Özlem Kanburoğlu Meletli +8 more
doaj +1 more source
A case of rapidly increasing cabergoline-resistant male prolactinoma
Cabergoline, a dopamine agonist, is the first-line drug for treating prolactinoma. However, some rare cases exhibit resistance to cabergoline. Here, we report a rare case of prolactinoma in a male patient that recurred in a short period while the patient
Toshiya Ichinose +2 more
doaj +1 more source
Introduction: Prolactinomas can induce castrate-level testosterone suppression by dysregulating the hypothalamic-pituitary-gonadal axis. While hypogonadism typically confers a reduced risk for prostate cancer (PCa), malignancy can still occur ...
Tara A. Seibert +2 more
doaj +1 more source
Prolactinoma Concomitante a un Caso de Glaucoma Primario de Ángulos Abiertos, a propósito de un Caso
En la práctica clínica oftalmológica diaria es frecuente evaluar pacientes que presentan Glaucoma primario de ángulos abiertos1,2. En algunos casos se pueden presentar adicionalmente lesiones en nervio óptico de origen intracraneal4.
Oscar Guillermo Márquez Valdez
doaj +1 more source
Prolactinoma is the most prevalent pituitary neuroendocrine tumor and dopamine agonists (DAs) targeting dopamine D2 receptor (DRD2) are recommended as the first-line treatment. However, varying degrees of DA resistance limit patient benefit.
Yuyang Peng +8 more
doaj +1 more source
Central serous chorioretinopathy following intramuscular testosterone therapy in prolactinoma. [PDF]
Jha V, Dutta P, Grossman AB, Bashyal B.
europepmc +1 more source
Chinese consensus on the diagnosis and treatment of prolactinomas (2025 edition). [PDF]
Lin S +18 more
europepmc +1 more source
Recurrent nasal bleed as initial presenting complaint: a rare complication of giant prolactinoma in a 39-year-old. [PDF]
Fahim W +5 more
europepmc +1 more source

